Fractyl Health Inc (NAS:GUTS)

Q2 2025 Fractyl Health Inc Earnings Call Transcript

Aug 12, 2025 / 08:30 PM GMT

Release Date Price: $0.9839 (+0.71%)

Transcript 10-Q8-K

Key Points

Positve

Fractyl Health Inc (GUTS) has strengthened its financial position with a $23 million public offering, potentially increasing proceeds to $69 million.
The company has reduced its cash burn rate from $25.4 million in Q1 to $19.8 million in Q2, indicating improved financial discipline.
Fractyl Health Inc (GUTS) reported promising data from its Ravita program, showing up to 2 years of weight maintenance and blood sugar control.
Enrollment for the Remain one pivotal study is complete, with favorable safety profiles and strong procedural consistency observed.
The company has secured two new US patents, reinforcing its leadership in gut-targeted metabolic therapy.

Negative

Net loss for the quarter increased to $27.9 million from $17.2 million in Q2 2024, largely due to changes in non-cash fair value of notes and warrants.
R&D expenses rose to $21.2 million compared to $16.8 million in the same quarter last year, reflecting increased costs in advancing clinical studies.
The company has only $22.3 million in cash and cash equivalents as of June 30th, which may limit operational flexibility.
There is uncertainty regarding the long-term durability of the Ravita treatment, as further data is needed to confirm its efficacy over extended periods.
The company faces risks and uncertainties related to forward-looking statements, which could impact future results.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GUTS.OQ - Fractyl Health Inc
Q2 2025 Fractyl Health Inc Earnings Call
Aug 12, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon. Welcome to Fractal Health 2nd quarter 2025 financial results and business updates call. As a reminder, this conference call is being recorded at this time, all participants are in listen-only mode.

There'll be a Q&A session following management prepare remarks. I'll now turn the call over to Brian Luque, head of investor relations and corporate development at FAO. Brian, you may now begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you. This afternoon we issued a press release that outlines the topics we plan to discuss today. This release is

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.